Sponsor:
Fox Chase Cancer Center
Code:
NCT03094884
Conditions
Lung Cancer
Esophageal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pulsed Low Dose Radiation
Carboplatin
Paclitaxel
Brief summary:
Conditions
Lung Cancer
Esophageal Cancer
Study ID
NCT03094884
Start date
Feb 24, 2017
Status verified date
May, 2023
Completion date
May 1, 2025
Anticipated
Primary completion date
May 1, 2024
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
40 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Pulsed Low dose radiation with Carboplatin/Paclitaxel
Interventions
Pulsed Low Dose Radiation
Carboplatin
Paclitaxel
Primary outcome measure
Central contacts
Locations
Fox Chase Cancer Center
Recruiting
Philadelphia, Pennsylvania, United States, 19111
Contacts
Sponsor
Fox Chase Cancer Center
Last update posted
May 23, 2023
Last verified
May, 2023
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Fox Chase Cancer Center on 2023-05-23.